Proposed Data Collection Submitted for Public Comment and Recommendations, 59791-59792 [2022-21318]
Download as PDF
Federal Register / Vol. 87, No. 190 / Monday, October 3, 2022 / Notices
Public Participation
Oral Public Comment: The public
comment period is scheduled on
December 8, 2022, from 12 p.m. until
12:15 p.m., EST. Individuals wishing to
make a comment during the public
comment period, please email your
name, organization, and phone number
by November 23, 2022, to LEPAC@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–21405 Filed 9–30–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–1265; Docket No. CDC–2022–
0121]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled the Chronic
Disease Self-Management
Questionnaire. The questionnaire used
for this study will assess Chronic
Disease Self-Management participant
health behaviors and overall health
before and after a six-week workshop.
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
19:00 Sep 30, 2022
CDC must receive written
comments on or before December 2,
2022.
DATES:
Jkt 259001
You may submit comments,
identified by Docket No. CDC–2022–
0121 by any of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
ADDRESSES:
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
59791
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Evaluation of the Chronic Disease
Self-Management Program in the US
Affiliated Pacific Islands (OMB Control
No. 0920–1265, Exp. 06/30/2021)—
Reinstatement—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
NCCDPHP is evaluating the
implementation of Stanford University’s
Chronic Disease Self-Management
Program (CDSMP) in the U.S. Affiliated
Pacific Islands (USAPI). These
jurisdictions include American Samoa,
Guam, the Commonwealth of the
Northern Mariana Islands, the Republic
of Palau, the Republic of the Marshall
Islands, and the Federated States of
Micronesia.
The purpose of the evaluation is: (1)
to understand how CDSMP is being
implemented in the region; (2) to
identify barriers and facilitators to
implementation; (3) to monitor fidelity
to Stanford University’s model and
document adaptations to the
curriculum; and (4) to understand the
self-reported effects of CDSMP on
program participants. Because this is the
first time CDSMP is being implemented
in the USAPI, we do not know if the
intervention, which has proven to
improve health outcomes in many
ethnic groups within the United States,
will lead to improved health outcomes
for these communities. Collecting this
data helps CDC to assess fidelity to and
adaptations to the intervention, and to
understand if CDSMP, an evidencebased intervention, has the same effect
in the U.S. Affiliated Pacific Islands as
it has in multiple ethnic groups within
the United States.
CDC requests OMB approval for an
estimated 95 annual burden hours.
There are no costs to respondents other
than their time to participate.
E:\FR\FM\03OCN1.SGM
03OCN1
59792
Federal Register / Vol. 87, No. 190 / Monday, October 3, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Program Participant ..............
Chronic Disease Self-Management Workshop Evaluation.
Chronic Disease Self-Management Questionnaire (Pre-Post Test).
Program Participant ..............
Total ...............................
.......................................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–21318 Filed 9–30–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This virtual meeting is open
to the public, limited only by the
number of audio and web conference
lines (500 audio and web conference
lines are available). Time will be
available for public comment.
Registration is required.
DATES: The meeting will be held on
November 3, 2022, from 12 p.m. to 2:30
p.m., EST.
ADDRESSES: To register for this web
conference, please go to: www.cdc.gov/
hicpac. All registered participants will
receive the meeting link and
instructions shortly before the meeting.
Please click the link below to join the
webinar: https://cdc.zoomgov.com/j/
1618328215?pwd=NWx1cGZGS3Y0THd
zS1RraHBpZFNZZz09.
Meeting ID: 161 832 8215.
Passcode: 76683972.
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., Program Analyst,
HICPAC, Division of Healthcare Quality
Promotion (DHQP), National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), CDC, 1600 Clifton
Road NE, Mailstop H16–3, Atlanta,
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
21:31 Sep 30, 2022
Jkt 259001
1
10/60
32
190
2
10/60
63
........................
........................
........................
95
Public Participation
Oral Public Comment: Time will be
available for public comment. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated, following the last call
for comments.
Written Public Comment: The public
may submit written comments in
advance of the meeting. Comments
should be submitted in writing by email
to the contact person listed above. The
deadline for receipt of written public
comment is October 24, 2022. All
requests must contain the submitter’s
name, address, and organizational
affiliation, as well as the topic being
addressed. Written comments should
not exceed one single-spaced typed page
in length. Written comments received in
Frm 00023
Fmt 4703
Total burden
(in hr)
190
Georgia 30329–4027, Telephone: (404)
718–8039; Email: HICPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
the Director, DHQP; the Director,
NCEZID; the Director, CDC; and the
Secretary, Department of Health and
Human Services, regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; Isolation Precautions
Guideline Workgroup; Neonatal
Intensive Care Unit Guideline
Workgroup; Neonatal Pediatric
Surveillance Workgroup; and Dental
Unit Waterlines Guideline Update.
Agenda items are subject to change as
priorities dictate.
PO 00000
Average
burden per
response
(in hr)
Number of
responses per
respondent
Number of
respondents
Type of respondent
Sfmt 4703
advance of the meeting will be included
in the official record of the meeting.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–21406 Filed 9–30–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3424–CN]
Medicare and Medicaid Programs:
Approval of Application From Det
Norske Veritas for Continued Hospital
Accreditation Program; Correction
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final notice; correction.
AGENCY:
This document corrects a
technical error that appeared in the final
notice published in the Federal Register
on September 6, 2022, entitled
‘‘Approval of Application From Det
Norske Veritas for Continued Hospital
Accreditation Program.’’
Effective date: This correction is
effective October 3, 2022.
Applicability date: The decision
announced in the final notice is
effective through September 26, 2026.
FOR FURTHER INFORMATION CONTACT: Joy
Webb, (410) 786–1667 or Lillian
Williams, (410) 786–8636.
SUPPLEMENTARY INFORMATION:
SUMMARY:
E:\FR\FM\03OCN1.SGM
03OCN1
Agencies
[Federal Register Volume 87, Number 190 (Monday, October 3, 2022)]
[Notices]
[Pages 59791-59792]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21318]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1265; Docket No. CDC-2022-0121]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled the Chronic Disease Self-Management Questionnaire. The
questionnaire used for this study will assess Chronic Disease Self-
Management participant health behaviors and overall health before and
after a six-week workshop.
DATES: CDC must receive written comments on or before December 2, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0121 by any of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Evaluation of the Chronic Disease Self-Management Program in the US
Affiliated Pacific Islands (OMB Control No. 0920-1265, Exp. 06/30/
2021)--Reinstatement--National Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
NCCDPHP is evaluating the implementation of Stanford University's
Chronic Disease Self-Management Program (CDSMP) in the U.S. Affiliated
Pacific Islands (USAPI). These jurisdictions include American Samoa,
Guam, the Commonwealth of the Northern Mariana Islands, the Republic of
Palau, the Republic of the Marshall Islands, and the Federated States
of Micronesia.
The purpose of the evaluation is: (1) to understand how CDSMP is
being implemented in the region; (2) to identify barriers and
facilitators to implementation; (3) to monitor fidelity to Stanford
University's model and document adaptations to the curriculum; and (4)
to understand the self-reported effects of CDSMP on program
participants. Because this is the first time CDSMP is being implemented
in the USAPI, we do not know if the intervention, which has proven to
improve health outcomes in many ethnic groups within the United States,
will lead to improved health outcomes for these communities. Collecting
this data helps CDC to assess fidelity to and adaptations to the
intervention, and to understand if CDSMP, an evidence-based
intervention, has the same effect in the U.S. Affiliated Pacific
Islands as it has in multiple ethnic groups within the United States.
CDC requests OMB approval for an estimated 95 annual burden hours.
There are no costs to respondents other than their time to participate.
[[Page 59792]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in (in hr)
respondent hr)
----------------------------------------------------------------------------------------------------------------
Program Participant........... Chronic Disease 190 1 10/60 32
Self-Management
Workshop
Evaluation.
Program Participant........... Chronic Disease 190 2 10/60 63
Self-Management
Questionnaire
(Pre-Post Test).
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 95
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-21318 Filed 9-30-22; 8:45 am]
BILLING CODE 4163-18-P